Search

Search Results

• ADVANCES IN THE PATHOPHYSIOLOGY AND MANAGEMENT OF CANCER PAIN: A SCOPING REVIEW Y. Tran Van¹, A. Paladini², V.P. Pham¹, A.A. Al Alwany³, G. Farì⁴, A. Caruso⁵, M. Mercieri⁶, M.L.G. Leoni⁷, J.V. Pergolizzi⁸, A.D. Kaye⁹, F. Breve¹⁰, A. Corriero¹¹, C. Gharibo¹², G. Varrassi¹³ | ¹Department of Biomedical Engineering, International University, Vietnam National University, Ho Chi Minh City, Vietnam; ²Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy; ³College of Medicine, University of Baghdad, Iraq; ⁴Department of Experimental Medicine (Di.Me.S.), University of Salento, Lecce, Italy; ⁶Department of Surgery, ASST Lodi, Lodi, Italy; ⁷Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Italy; ⁸NEMA Research Inc., Naples, FL, USA; ⁹Department of Anesthesiology, LSU Health, Shreveport, LA, USA; ¹⁰School of Pharmacy, Temple University, Philadelphia, PA, USA; ¹¹Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", Bari, Italy; ¹²Department of Anesthesiology, NYU Grossman School of Medicine, New York, NY, USA; ¹³Fondazione Paolo Procacci, Rome, Italy

  Fondazione Paolo Procacci

  2026-05-06

  https://doi.org/10.4081/ahr.2026.202

  1

• EMERGING DRUGS OF ABUSE IN THE CHRONIC PAIN POPULATION: A CLINICAL PHARMACOLOGY PERSPECTIVE ON KRATOM, NOVEL SYNTHETIC OPIOIDS, DESIGNER BENZODIAZEPINES, GABAPENTINOIDS, XYLAZINE, AND KETAMINE F. Breve¹, G. Varrassi², J. Pergolizzi³, R. Raffa⁴ | ¹Mid Atlantic PharmaTech Consultants LLC, Ventnor City, NJ, USA; Temple University School of Pharmacy, Philadelphia, PA, USA; ²Fondazione Paolo Procacci, Rome, Italy; ³NEMA Research Inc., Naples, FL, USA; ⁴Temple University School of Pharmacy, Philadelphia, PA, USA; University of Arizona College of Pharmacy, Tucson, AZ, USA

  Fondazione Paolo Procacci

  2026-05-06

  https://doi.org/10.4081/ahr.2026.152

  1